FindTrial
Sign In

Continuously ambulatory rhythm monitoring and predictors of electrocardio-related adverse events in 30 days after transcatheter aortic valve replacement

Continuously ambulatory rhythm monitoring and predictors of electrocardio-related adverse events in 30 days after transcatheter aortic valve replacement

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000041244
Enrollment
Unknown
Registered
2020-12-22
Start date
2021-01-01
Completion date
Unknown
Last updated
2021-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe Aortic Stenosis

Interventions

1:transcatheter aortic valve replacement

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 98 Years

Inclusion criteria

Inclusion criteria: Patients with severe aortic stenosis, who have TAVR indications (determined according to 2017 ESC / EACTS and 2017 AHA / ACC Guidelines for the management of valvular heart disease) and finally underwent TAVR in West China Hospital of Sichuan University.

Exclusion criteria

Exclusion criteria: (1) Refused to wear ambulatory wristband monitor; (2) Bilateral upper limb disability; (3) The color of wrist is abnormal; (4) Severe occlusive vascular disease of upper limb; (5) The upper limbs were obviously edematous.

Design outcomes

Primary

MeasureTime frame
Incidence of high-degree/complete atrioventricular block;—

Countries

China

Contacts

Public ContactChen Mao

Department of Cardilogy, West China Hospital, Sichuan University, Chengdu, China

hmaochen@vip.sina.com+86 18980602046

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026